Patent details

EP3638206 Title: BIOERODIBLE DRUG DELIVERY DEVICES

Basic Information

Publication number:
EP3638206
PCT Application Number:
US2018037082
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188181937
PCT Publication Number:
WO2018231811
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BIOERODIBLE DRUG DELIVERY DEVICES
French Title of Invention:
DISPOSITIFS D'ADMINISTRATION DE MÉDICAMENTS BIOÉRODABLE
German Title of Invention:
BIOERODIERBARE ARZNEIMITTELABGABEVORRICHTUNGEN
SPC Number:

Dates

Filing date:
12/06/2018
Grant date:
26/03/2025
EP Publication Date:
22/04/2020
PCT Publication Date:
20/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/03/2025
EP B1 Publication Date:
26/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/03/2025
 
 

Name:
EyePoint Pharmaceuticals, Inc.
Address:
480 Pleasant Street Suite B300, Watertown, MA 02472, United States (US)

Inventor

1

Name:
CHEN, Jian, Bing
Address:
United States (US)

2

Name:
GUO, Hong
Address:
United States (US)

Priority

Priority Number:
201762518739 P
Priority Date:
13/06/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61P 27/02; A61K 9/00; A61K 9/70; A61K 31/58;

Publication

European Patent Bulletin

1

Issue number:
202513
Publication date:
26/03/2025
Description:
Grant (B1)

2

Issue number:
202515
Publication date:
09/04/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages